MCID: HYP066
MIFTS: 61

Hyperglycemia

Categories: Blood diseases, Metabolic diseases

Aliases & Classifications for Hyperglycemia

MalaCards integrated aliases for Hyperglycemia:

Name: Hyperglycemia 12 74 29 54 6 42 43 15 71

Classifications:



External Ids:

Disease Ontology 12 DOID:4195
MeSH 43 D006943
NCIt 49 C26797
SNOMED-CT 67 80394007
ICD10 32 R73.9
UMLS 71 C0020456

Summaries for Hyperglycemia

MedlinePlus : 42 Hyperglycemia means high blood sugar or glucose. Glucose comes from the foods you eat. Insulin is a hormone that moves glucose into your cells to give them energy. Hyperglycemia happens when your body doesn't make enough insulin or can't use it the right way. People with diabetes can get hyperglycemia from not eating the right foods or not taking medicines correctly. Other problems that can raise blood sugar include infections, certain medicines, hormone imbalances, or severe illnesses.

MalaCards based summary : Hyperglycemia is related to diabetes mellitus, permanent neonatal and transient neonatal diabetes mellitus, and has symptoms including seizures, fever and dyspnea. An important gene associated with Hyperglycemia is MALAT1 (Metastasis Associated Lung Adenocarcinoma Transcript 1), and among its related pathways/superpathways are Developmental Biology and Aldosterone synthesis and secretion. The drugs Pancrelipase and Lixisenatide have been mentioned in the context of this disorder. Affiliated tissues include endothelial, liver and kidney, and related phenotypes are homeostasis/metabolism and growth/size/body region

Wikipedia : 74 Hyperglycemia (also spelled hyperglycaemia or hyperglycamia), is a condition in which an excessive... more...

Related Diseases for Hyperglycemia

Diseases related to Hyperglycemia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 871, show less)
# Related Disease Score Top Affiliating Genes
1 diabetes mellitus, permanent neonatal 33.6 PDX1 KCNJ11 INS GCK GCG ABCC8
2 transient neonatal diabetes mellitus 33.5 PDX1 KCNJ11 INS GCK ABCC8
3 maturity-onset diabetes of the young, type 2 33.4 PDX1 KCNJ11 INS HNF1A GCK ABCC8
4 diabetes mellitus, ketosis-prone 33.2 SLC5A2 KCNJ11 INS GCG DPP4 ALB
5 microvascular complications of diabetes 1 33.2 SST INS IGF1 AKR1B1
6 donohue syndrome 33.0 KCNJ11 IRS1 INSR INS IGF1 GCK
7 diabetes mellitus, insulin-dependent, 20 32.7 INS IGF1 HNF1A
8 hyperinsulinism 32.6 SST PPARG LEP KCNJ11 IRS1 INSR
9 pancreatic cholera 32.6 SST GCG
10 diabetes mellitus, insulin-dependent 32.4 SST SLC5A2 PDX1 LEP INSR INS
11 hypoglycemia 32.2 SST KCNJ11 INSR INS IGF1 IAPP
12 diabetes mellitus, noninsulin-dependent 32.0 SST SLC5A2 PPARG PDX1 LEP KCNJ11
13 microvascular complications of diabetes 5 31.9 INS IGF1 ALB AKR1B1
14 lipid metabolism disorder 31.8 PPARG LEP IRS1 INSR INS ADIPOQ
15 fatty liver disease, nonalcoholic 1 31.5 LEP INS ADIPOQ
16 gestational diabetes 31.5 PPARG LEP KCNJ11 IRS1 INSR INS
17 atherosclerosis susceptibility 31.5 PPARG LEP INS ALB ADIPOQ
18 vascular disease 31.5 PPARG LEP INS IGF1 ALB ADIPOQ
19 peripheral nervous system disease 31.4 INS IGF1 GCG ALB AKR1B1
20 diabetic neuropathy 31.4 LEP INS AKR1B1
21 myocardial infarction 31.3 PPARG LEP INS IGF1 DPP4 ALB
22 retinal vascular disease 31.3 INS IGF1 ALB AKR1B1
23 glucose intolerance 31.3 PPARG LEP KCNJ11 IRS1 INSR INS
24 autonomic neuropathy 31.2 INS GCG ALB AKR1B1
25 exudative vitreoretinopathy 1 31.2 INS IGF1 ALB
26 acute insulin response 31.2 KCNJ11 INS GCG ABCC8
27 kidney disease 31.2 PPARG LEP INS GCG DPP4 ALB
28 microvascular complications of diabetes 3 31.2 MALAT1 INS ALB AKR1B1
29 chronic kidney disease 31.2 LEP INS IGF1 ALB ADIPOQ
30 acute cystitis 31.2 SLC5A2 INS DPP4 ALB
31 insulinoma 31.1 SST PDX1 INS IAPP HNF1A GCK
32 acromegaly 31.1 SST LEP INS IGF1 ADIPOQ
33 diabetic encephalopathy 31.1 IRS1 INS IGF1
34 macular retinal edema 31.1 INS ALB AKR1B1
35 insulin-like growth factor i 31.0 SST LEP IRS1 INSR INS IGF1
36 maturity-onset diabetes of the young 31.0 SST PPARG PDX1 KCNJ11 IRS1 INS
37 liver disease 31.0 LEP IRS1 INSR INS ALB ADIPOQ
38 arteries, anomalies of 31.0 LEP INS ALB ADIPOQ
39 polycystic ovary syndrome 31.0 LEP IRS1 INSR INS IGF1 ADIPOQ
40 proteasome-associated autoinflammatory syndrome 1 31.0 PPARG INS ALB ADIPOQ
41 heart disease 31.0 PPARG LEP INS IGF1 GCG ALB
42 non-alcoholic fatty liver disease 31.0 PPARG LEP IRS1 INSR INS GCG
43 neonatal diabetes mellitus 30.9 PDX1 KCNJ11 INS GCK GCG ABCC8
44 non-alcoholic steatohepatitis 30.9 PPARG INS ADIPOQ
45 bone resorption disease 30.9 LEP INS IGF1 ALB
46 intermediate coronary syndrome 30.9 INS DPP4 ALB
47 monogenic diabetes 30.9 PDX1 KCNJ11 INS HNF1A GCK ABCC8
48 hyperandrogenism 30.9 PPARG INSR INS IGF1 ADIPOQ
49 hyperuricemia 30.9 LEP INS ALB
50 sleep apnea 30.8 LEP INS IGF1 ALB ADIPOQ
51 hypothyroidism 30.8 SST LEP INS IGF1 ALB ADIPOQ
52 hypoglycemic coma 30.8 INS GCG DPP4
53 fasting hypoglycemia 30.8 INSR IGF1
54 multiple endocrine neoplasia, type i 30.8 SST PDX1 INS GCG
55 background diabetic retinopathy 30.7 INS ALB AKR1B1
56 eye disease 30.7 SST INS IGF1 ALB AKR1B1
57 maturity-onset diabetes of the young, type 3 30.7 PDX1 KCNJ11 INS HNF1A GCK ABCC8
58 anorexia nervosa 30.6 LEP INS IGF1 GCG ADIPOQ
59 hyperinsulinemic hypoglycemia 30.6 SST PDX1 KCNJ11 INSR INS HNF1A
60 conn's syndrome 30.6 SST LEP IGF1 ADIPOQ
61 hyperthyroidism 30.6 SST LEP INS IGF1 ALB
62 uremia 30.6 LEP INS ALB
63 islet cell tumor 30.6 SST INSR INS IGF1 IAPP GCG
64 body mass index quantitative trait locus 11 30.6 PPARG LEP KCNJ11 IRS1 INSR INS
65 overnutrition 30.6 PPARG LEP IRS1 INS IGF1 GCG
66 abdominal obesity-metabolic syndrome 1 30.6 PPARG LEP INSR INS GCK GCG
67 tuberous sclerosis 30.6 SST IRS1 INS IGF1
68 diabetic autonomic neuropathy 30.5 INS GCG AKR1B1
69 critical illness polyneuropathy 30.5 INS ALB
70 cardiovascular system disease 30.5 PPARG LEP INS IGF1 ALB ADIPOQ
71 dumping syndrome 30.5 SST INS GCG
72 somatostatinoma 30.5 SST INS GCG
73 glycogen storage disease 30.5 INS IGF1 HNF1A ALB
74 pituitary apoplexy 30.5 SST INS IGF1
75 pancreatic agenesis 30.5 PDX1 KCNJ11 INS GCK ABCC8
76 hirata disease 30.5 INS GCG
77 carbohydrate metabolic disorder 30.5 SST KCNJ11 INS GCK GCG ABCC8
78 renal cysts and diabetes syndrome 30.5 PDX1 KCNJ11 HNF1A GCK ABCC8
79 pericarditis 30.5 LEP ALB ADIPOQ
80 osteoporosis 30.4 PPARG LEP IRS1 INS IGF1 IAPP
81 retinal microaneurysm 30.4 INS AKR1B1
82 thyroid gland disease 30.4 SST INS IGF1 ALB
83 prediabetes syndrome 30.4 SLC5A2 PPARG LEP IRS1 INS IGF1
84 celiac disease 1 30.4 INS IGF1 GCG DPP4 ALB
85 fetal macrosomia 30.3 LEP INSR INS IGF1
86 genetic obesity 30.3 LEP IGF1
87 fatty liver disease 30.3 PPARG MALAT1 LEP IRS1 INSR INS
88 familial hyperlipidemia 30.3 PPARG LEP INS ADIPOQ
89 leptin deficiency or dysfunction 30.3 PPARG LEP IRS1 INS IGF1 GCG
90 eating disorder 30.3 LEP GCG ALB ADIPOQ
91 pre-eclampsia 30.2 MALAT1 LEP INS IGF1 ALB ADIPOQ
92 amenorrhea 30.2 LEP INS IGF1
93 maturity-onset diabetes of the young, type 1 30.2 PDX1 LEP KCNJ11 INS HNF1A GCK
94 pancreas disease 30.1 SST LEP INS IGF1 GCG DPP4
95 migraine with or without aura 1 30.1 LEP INS IAPP ALB
96 hypopituitarism 30.0 LEP INS IGF1
97 liver cirrhosis 30.0 SST MALAT1 LEP ALB ADIPOQ
98 inflammatory bowel disease 30.0 PPARG LEP IGF1 GCG DPP4 ALB
99 hypertension, essential 29.9 SST SLC5A2 PPARG LEP KCNJ11 IRS1
100 diabetes mellitus 29.8 SST SLC5A2 PPARG PDX1 MALAT1 LEP
101 glucose metabolism disease 29.8 SST SLC5A2 PPARG LEP KCNJ11 IRS1
102 schizophrenia 29.7 SST LEP INS IGF1 DPP4 ALB
103 mitochondrial complex iii deficiency, nuclear type 6 11.6
104 diabetes and deafness, maternally inherited 11.5
105 diabetic cataract 11.4
106 diabetes mellitus, insulin-dependent, 2 11.3
107 mitochondrial complex iii deficiency 11.3
108 brittle diabetes 11.3
109 pancreas, dorsal, agenesis of 11.2
110 renal glucosuria 11.2
111 diabetes mellitus, transient neonatal, 1 11.2
112 histiocytosis-lymphadenopathy plus syndrome 11.2
113 diabetes mellitus, 6q24-related transient neonatal 11.2
114 glycogen storage disease 0, liver 11.0
115 diabetes mellitus, insulin-dependent, 5 11.0
116 diabetes mellitus, insulin-dependent, 12 11.0
117 diabetes mellitus, insulin-dependent, 10 11.0
118 megalencephaly-capillary malformation-polymicrogyria syndrome 11.0
119 diabetes mellitus, insulin-dependent, 19 11.0
120 diabetes mellitus, transient neonatal, 2 11.0
121 diabetes mellitus, transient neonatal, 3 11.0
122 cataract 47 11.0
123 diabetes mellitus, insulin-dependent, 22 11.0
124 aromatase deficiency 11.0
125 multiple mitochondrial dysfunctions syndrome 11.0
126 vipoma 11.0
127 insulin-resistance type b 11.0
128 x-linked lissencephaly with abnormal genitalia 11.0
129 munchausen by proxy 10.8 KCNJ11 GCK ABCC8
130 hyperinsulinemic hypoglycemia, familial, 6 10.8 INS GCK ABCC8
131 hyperinsulinemic hypoglycemia, familial, 7 10.8 KCNJ11 GCK ABCC8
132 postgastrectomy syndrome 10.8 SST INS GCG
133 asphyxia neonatorum 10.8 KCNJ11 INS ABCC8
134 erythematosquamous dermatosis 10.8 INS GCG
135 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 10.8 KCNJ11 INS ABCC8
136 pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities 10.8 INSR INS IGF1
137 severe nonproliferative diabetic retinopathy 10.8 INS ALB AKR1B1
138 idiopathic edema 10.8 PPARG INS ADIPOQ
139 hyperinsulinemic hypoglycemia, familial, 2 10.8 SST KCNJ11 INS ABCC8
140 pituitary infarct 10.8 SST INS IGF1
141 maturity-onset diabetes of the young, type 11 10.8 PDX1 KCNJ11 ABCC8
142 chronic duodenal ileus 10.8 KCNJ11 ALB
143 acidophil adenoma 10.8 SST INS IGF1
144 abnormality of glucagon secretion 10.8 SST IAPP GCG
145 maturity-onset diabetes of the young, type 14 10.8 PDX1 HNF1A GCK
146 autonomic nervous system disease 10.8 INS GCG ALB AKR1B1
147 pancreatic endocrine carcinoma 10.8 SST INS GCG
148 adenosquamous bile duct carcinoma 10.8 GCG DPP4
149 alzheimer disease 6 10.8 INS IAPP GCG
150 maturity-onset diabetes of the young, type 13 10.8 PDX1 KCNJ11 GCK ABCC8
151 maturity-onset diabetes of the young, type 8, with exocrine dysfunction 10.8 PDX1 KCNJ11 GCK ABCC8
152 maturity-onset diabetes of the young, type 7 10.8 PDX1 KCNJ11 GCK ABCC8
153 maturity-onset diabetes of the young, type 9 10.8 PDX1 KCNJ11 GCK ABCC8
154 marasmus 10.8 INS IGF1 ALB
155 secondary adrenal insufficiency 10.8 INS IGF1
156 functional gastric disease 10.8 SST INS GCG ALB
157 squamous cell bile duct carcinoma 10.7 GCG DPP4
158 hyperpituitarism 10.7 SST INS IGF1
159 contractures, pterygia, and variable skeletal fusions syndrome 1a 10.7 SST KCNJ11 INS HNF1A GCK
160 maturity-onset diabetes of the young, type 10 10.7 PDX1 KCNJ11 INS GCK ABCC8
161 transient refractive change 10.7 SST INS
162 pituitary gland disease 10.7 SST INS IGF1 GCG
163 maturity-onset diabetes of the young, type 6 10.7 PDX1 KCNJ11 HNF1A GCK ABCC8
164 decubitus ulcer 10.7 INS IGF1 ALB
165 diffuse idiopathic skeletal hyperostosis 10.7 INS IGF1 ALB
166 endocrine organ benign neoplasm 10.7 SST INS IGF1 GCG
167 gastrointestinal system benign neoplasm 10.7 SST INS IAPP GCG
168 maturity-onset diabetes of the young, type 4 10.7 PDX1 KCNJ11 INS HNF1A GCK ABCC8
169 parathyroid gland disease 10.7 INS IGF1 ALB
170 mixed cell adenoma 10.7 IRS1 IGF1
171 adrenal gland disease 10.7 SST INS IGF1
172 vein disease 10.7 SST INS ALB
173 cystinosis 10.7 SST INS ALB
174 rare diabetes mellitus type 2 10.7 KCNJ11 IRS1 INSR HNF1A GCK ABCC8
175 duodenal gastrinoma 10.7 SST GCG
176 lens disease 10.7 INS ALB AKR1B1
177 hypothalamic obesity 10.7 LEP INS IGF1
178 acquired generalized lipodystrophy 10.7 LEP INS ADIPOQ
179 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 10.7 LEP INS ADIPOQ
180 cervical large cell neuroendocrine carcinoma 10.7 SST GCG
181 autosomal genetic disease 10.7 INS IGF1 GCK ALB
182 hyperprolactinemia 10.7 SST INS IGF1
183 pancreatic colloid cystadenoma 10.7 SLC5A2 GCG DPP4
184 hypothalamic disease 10.7 LEP INS IGF1
185 hair disease 10.7 INS IGF1 ALB
186 abdominal obesity-metabolic syndrome quantitative trait locus 2 10.7 PPARG LEP INS ADIPOQ
187 nasopharyngitis 10.7 SLC5A2 INS GCG DPP4
188 complete generalized lipodystrophy 10.7 PPARG LEP INS ADIPOQ
189 lipodystrophy, congenital generalized, type 1 10.7 PPARG LEP INS ADIPOQ
190 lipodystrophy, congenital generalized, type 2 10.6 PPARG LEP INS
191 skin tag 10.6 LEP INS IGF1
192 congenital generalized lipodystrophy 10.6 PPARG LEP INS ADIPOQ
193 sex development disorder 10.6 LEP INS IGF1 ADIPOQ
194 peptic ulcer disease 10.6 SST PPARG ALB
195 adult syndrome 10.6 LEP INS IGF1 ADIPOQ
196 familial partial lipodystrophy 10.6 PPARG LEP INS ADIPOQ
197 pancreatic cystadenoma 10.6 SST PDX1 INS IAPP GCK GCG
198 idiopathic recurrent pericarditis 10.6 LEP ADIPOQ
199 sleep disorder 10.6 LEP INS IGF1 ADIPOQ
200 persistent fetal circulation syndrome 10.6 LEP INS IGF1 ALB
201 adrenal cortex disease 10.6 SST LEP INS IGF1
202 lipodystrophy, familial partial, type 2 10.6 PPARG LEP INS GCG ADIPOQ
203 cholelithiasis 10.6 SST LEP INS ALB
204 obesity-hypoventilation syndrome 10.6 LEP ADIPOQ
205 placental choriocarcinoma 10.6 LEP INS ALB
206 short bowel syndrome 10.6 SST LEP IGF1 GCG
207 microvascular complications of diabetes 4 10.6
208 microvascular complications of diabetes 6 10.6
209 microvascular complications of diabetes 7 10.6
210 portal hypertension 10.6 SST INS ALB
211 bone remodeling disease 10.6 LEP INS IGF1 ALB
212 pigmentation disease 10.6 LEP INSR INS IGF1 ALB
213 lipid storage disease 10.6 PPARG LEP INS ALB ADIPOQ
214 nutritional deficiency disease 10.6 LEP IGF1 ALB ADIPOQ
215 duodenal somatostatinoma 10.6 SST INS
216 anovulation 10.6 LEP INS IGF1
217 protein-energy malnutrition 10.6 LEP IGF1 ALB
218 ischemia 10.6
219 specific developmental disorder 10.6 LEP INS IGF1 ALB
220 apnea, obstructive sleep 10.6 LEP INS IGF1 GCG ALB ADIPOQ
221 silent myocardial infarction 10.6 SLC5A2 INS
222 inherited metabolic disorder 10.6 PPARG LEP INS GCG ALB ADIPOQ
223 lysosomal storage disease 10.6 LEP INS ALB ADIPOQ
224 severe pre-eclampsia 10.6 LEP ALB ADIPOQ
225 acanthosis nigricans 10.6 PPARG LEP INSR INS IGF1 ADIPOQ
226 prader-willi syndrome 10.6 LEP INS IGF1 GCG ADIPOQ
227 ocular motor apraxia 10.5
228 pancreatic gastrinoma 10.5 SST GCG
229 ovarian disease 10.5 LEP INSR INS IGF1 ALB
230 goiter 10.5 SST INS IGF1
231 balanoposthitis 10.5 SLC5A2 DPP4
232 functionless pituitary adenoma 10.5 SST IGF1
233 nontuberculous mycobacterial lung disease 10.5 LEP ADIPOQ
234 cerebrovascular disease 10.5
235 fibromyalgia 10.5 LEP INS IGF1
236 acute myocardial infarction 10.5
237 stroke, ischemic 10.5
238 hypertriglyceridemia, familial 10.5
239 inflammatory and toxic neuropathy 10.5 INS ALB
240 cerebral artery occlusion 10.4
241 seizure disorder 10.4
242 visual epilepsy 10.4
243 generalized atherosclerosis 10.4 INS ALB
244 chorea, childhood-onset, with psychomotor retardation 10.4
245 choreatic disease 10.4
246 neuropathy 10.4
247 turner syndrome 10.4 LEP INS IGF1
248 hypercholesterolemia, familial, 1 10.4
249 hypoxia 10.4
250 potter's syndrome 10.3 INS IGF1
251 lymphocytic leukemia 10.3
252 metabolic acidosis 10.3
253 brain injury 10.3
254 traumatic brain injury 10.3
255 coronary heart disease 1 10.3
256 body mass index quantitative trait locus 1 10.3
257 lactic acidosis 10.3
258 end stage renal failure 10.3
259 48,xyyy 10.3
260 endocrine pancreas disease 10.3 SST PPARG LEP KCNJ11 IRS1 INSR
261 leukemia, acute lymphoblastic 10.2
262 pancreatitis 10.2
263 acute pancreatitis 10.2
264 head injury 10.2
265 rapidly involuting congenital hemangioma 10.2
266 cytokine deficiency 10.2
267 pancreatic cancer 10.2
268 body mass index quantitative trait locus 9 10.2
269 body mass index quantitative trait locus 8 10.2
270 body mass index quantitative trait locus 4 10.2
271 body mass index quantitative trait locus 10 10.2
272 body mass index quantitative trait locus 7 10.2
273 body mass index quantitative trait locus 12 10.2
274 body mass index quantitative trait locus 14 10.2
275 body mass index quantitative trait locus 18 10.2
276 body mass index quantitative trait locus 19 10.2
277 body mass index quantitative trait locus 20 10.2
278 cardiac arrest 10.2
279 hypokalemia 10.2
280 yemenite deaf-blind hypopigmentation syndrome 10.2
281 toxic shock syndrome 10.2
282 congestive heart failure 10.2
283 cataract 10.2
284 neural tube defects 10.2
285 hydrops, lactic acidosis, and sideroblastic anemia 10.2
286 hyperlipoproteinemia, type iii 10.2
287 peripheral vascular disease 10.2
288 coronary artery anomaly 10.2
289 brain edema 10.2
290 periodontitis 10.2
291 status epilepticus 10.1
292 adenoma 10.1
293 cardiogenic shock 10.1
294 cystic fibrosis 10.1
295 preaxial hallucal polydactyly 10.1
296 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
297 acute kidney failure 10.1
298 acquired metabolic disease 10.1 SST SLC5A2 PPARG LEP IRS1 INS
299 fibrosis of extraocular muscles, congenital, 1 10.1
300 respiratory failure 10.1
301 pulmonary edema 10.1
302 polyneuropathy 10.1
303 transient cerebral ischemia 10.1
304 neutropenia 10.1
305 encephalopathy 10.1
306 autoimmune disease 10.1
307 renal cell carcinoma, nonpapillary 10.1
308 galactosemia 10.1
309 angina pectoris 10.1
310 atrial fibrillation 10.1
311 arteriosclerosis 10.1
312 subacute delirium 10.1
313 rare surgical neurologic disease 10.1
314 thrombophilia due to thrombin defect 10.0
315 movement disease 10.0
316 severe combined immunodeficiency 10.0
317 aortic aneurysm, familial abdominal, 1 10.0
318 intraocular pressure quantitative trait locus 10.0
319 microvascular complications of diabetes 2 10.0
320 thrombosis 10.0
321 hydrocephalus 10.0
322 glioblastoma multiforme 10.0
323 aortic aneurysm 10.0
324 aneurysm 10.0
325 anoxia 10.0
326 hepatocellular carcinoma 10.0
327 pheochromocytoma 10.0
328 enterocolitis 10.0
329 graft-versus-host disease 10.0
330 adrenal gland pheochromocytoma 10.0
331 aphasia 10.0
332 rickets 10.0
333 pertussis 10.0
334 gastroparesis 10.0
335 eclampsia 10.0
336 impotence 10.0
337 gastroenteritis 10.0
338 fibrosarcoma 10.0
339 carcinosarcoma 10.0
340 pneumonia 10.0
341 lymphopenia 10.0
342 carotid artery occlusion 10.0
343 perinatal necrotizing enterocolitis 10.0
344 meningitis 10.0
345 glioma 10.0
346 autonomic dysfunction 10.0
347 cerebral hypoxia 10.0
348 glial tumor 10.0
349 overgrowth syndrome 10.0
350 ataxia and polyneuropathy, adult-onset 9.9
351 prostatic hyperplasia, benign 9.9
352 bone mineral density quantitative trait locus 8 9.9
353 bone mineral density quantitative trait locus 15 9.9
354 hyperproinsulinemia 9.9
355 deficiency anemia 9.9
356 pulmonary hypertension 9.9
357 prostatic hypertrophy 9.9
358 acute leukemia 9.9
359 diarrhea 9.9
360 dental caries 9.9
361 prostatic adenoma 9.9
362 47,xyy 9.9
363 acute graft versus host disease 9.9
364 depression 9.9
365 spinal cord injury 9.9
366 atrial standstill 1 9.9
367 colorectal cancer 9.9
368 optic atrophy 1 9.9
369 ovarian cancer 9.9
370 lymphoma, hodgkin, classic 9.9
371 graves disease 1 9.9
372 asthma 9.9
373 lymphoma, non-hodgkin, familial 9.9
374 gastric cancer 9.9
375 muscle hypertrophy 9.9
376 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.9
377 hypophosphatemia 9.9
378 hyperphosphatemia 9.9
379 pain agnosia 9.9
380 childhood acute lymphocytic leukemia 9.9
381 diabetic angiopathy 9.9
382 male infertility 9.9
383 diabetic polyneuropathy 9.9
384 testicular disease 9.9
385 bilirubin metabolic disorder 9.9
386 idiopathic interstitial pneumonia 9.9
387 adenocarcinoma 9.9
388 pulmonary fibrosis 9.9
389 myopathy 9.9
390 pustulosis of palm and sole 9.9
391 retinal disease 9.9
392 central pontine myelinolysis 9.9
393 b-cell lymphoma 9.9
394 psoriasis 9.9
395 dysphagia 9.9
396 rare disease in surgical orthopedic 9.9
397 esophageal cancer 9.8
398 hair whorl 9.8
399 papillomatosis, confluent and reticulated 9.8
400 prostate cancer 9.8
401 down syndrome 9.8
402 arterial calcification, generalized, of infancy, 1 9.8
403 hemochromatosis, type 1 9.8
404 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.8
405 aging 9.8
406 helicobacter pylori infection 9.8
407 pulmonary disease, chronic obstructive 9.8
408 anxiety 9.8
409 major affective disorder 8 9.8
410 major affective disorder 9 9.8
411 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.8
412 chronic ulcer of skin 9.8
413 atrioventricular block 9.8
414 renal fibrosis 9.8
415 colorectal adenoma 9.8
416 sexual disorder 9.8
417 bone disease 9.8
418 mucositis 9.8
419 sensorineural hearing loss 9.8
420 bacterial infectious disease 9.8
421 hemiplegia 9.8
422 sarcoma 9.8
423 myopia 9.8
424 allergic hypersensitivity disease 9.8
425 hemosiderosis 9.8
426 leukemia 9.8
427 cholestasis 9.8
428 methylmalonic acidemia 9.8
429 neuroendocrine tumor 9.8
430 rectum cancer 9.8
431 constipation 9.8
432 focal epilepsy 9.8
433 iron metabolism disease 9.8
434 sensory peripheral neuropathy 9.8
435 teratoma 9.8
436 bipolar disorder 9.8
437 pseudomyxoma peritonei 9.8
438 pituitary adenoma 9.8
439 spindle cell sarcoma 9.8
440 infertility 9.8
441 placenta disease 9.8
442 mediastinitis 9.8
443 peritonitis 9.8
444 osteoarthritis 9.8
445 myeloid leukemia 9.8
446 vascular dementia 9.8
447 diabetic macular edema 9.8
448 diabetes insipidus 9.8
449 isolated methylmalonic acidemia 9.8
450 sudden sensorineural hearing loss 9.8
451 multiple endocrine neoplasia 9.8
452 cytomegalovirus infection 9.8
453 moderate and severe traumatic brain injury 9.8
454 systemic lupus erythematosus 9.7
455 motion sickness 9.7
456 polykaryocytosis inducer 9.7
457 retinoblastoma 9.7
458 triiodothyronine receptor auxiliary protein 9.7
459 tuberous sclerosis 1 9.7
460 wilms tumor 1 9.7
461 fanconi-bickel syndrome 9.7
462 fructose-1,6-bisphosphatase deficiency 9.7
463 hutterite cerebroosteonephrodysplasia syndrome 9.7
464 hydrocephalus, congenital, 1 9.7
465 myeloma, multiple 9.7
466 werner syndrome 9.7
467 leukemia, acute myeloid 9.7
468 branchiootic syndrome 1 9.7
469 macular degeneration, age-related, 1 9.7
470 homocysteinemia 9.7
471 ventricular fibrillation, paroxysmal familial, 1 9.7
472 cervical cancer 9.7
473 meningioma, radiation-induced 9.7
474 gastrointestinal stromal tumor 9.7
475 meningioma, familial 9.7
476 patent ductus arteriosus 1 9.7
477 human immunodeficiency virus type 1 9.7
478 hyperinsulinemic hypoglycemia, familial, 5 9.7
479 hyperinsulinemic hypoglycemia, familial, 4 9.7
480 carbonic anhydrase va deficiency, hyperammonemia due to 9.7
481 monocarboxylate transporter 1 deficiency 9.7
482 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.7
483 tendinopathy 9.7
484 tendinitis 9.7
485 bacterial sepsis 9.7
486 autoimmune pancreatitis 9.7
487 exanthem 9.7
488 autosomal recessive disease 9.7
489 peripheral artery disease 9.7
490 limb ischemia 9.7
491 colon adenoma 9.7
492 infective endocarditis 9.7
493 lymphoma 9.7
494 brain glioma 9.7
495 dextro-looped transposition of the great arteries 9.7
496 aortic atherosclerosis 9.7
497 endocarditis 9.7
498 renal hypertension 9.7
499 primary hyperparathyroidism 9.7
500 spinal meningioma 9.7
501 iron deficiency anemia 9.7
502 coronary thrombosis 9.7
503 hepatic coma 9.7
504 locked-in syndrome 9.7
505 dementia 9.7
506 focal segmental glomerulosclerosis 9.7
507 uveitis 9.7
508 gout 9.7
509 hepatic encephalopathy 9.7
510 hyperparathyroidism 9.7
511 benign paroxysmal positional nystagmus 9.7
512 rheumatic disease 9.7
513 mental depression 9.7
514 squamous cell carcinoma 9.7
515 epilepsy 9.7
516 hypogonadism 9.7
517 cerebral palsy 9.7
518 hyperostosis 9.7
519 keratopathy 9.7
520 reflex epilepsy 9.7
521 glomerulonephritis 9.7
522 pulmonary tuberculosis 9.7
523 gingivitis 9.7
524 breast adenocarcinoma 9.7
525 pancreatic ductal adenocarcinoma 9.7
526 choriocarcinoma 9.7
527 intermittent claudication 9.7
528 placental insufficiency 9.7
529 secretory meningioma 9.7
530 lymphoplasmacyte-rich meningioma 9.7
531 familial retinoblastoma 9.7
532 dystonia 9.7
533 bronchitis 9.7
534 combined t cell and b cell immunodeficiency 9.7
535 hypogonadotropism 9.7
536 childhood leukemia 9.7
537 myocarditis 9.7
538 retinal degeneration 9.7
539 lung disease 9.7
540 dermatophytosis 9.7
541 cholangitis 9.7
542 bacterial meningitis 9.7
543 pulmonary embolism 9.7
544 stomatitis 9.7
545 refractive error 9.7
546 alopecia 9.7
547 berardinelli-seip congenital lipodystrophy 9.7
548 athetosis 9.7
549 exencephaly 9.7
550 glycogen storage disease type 0 9.7
551 persistent vegetative state 9.7
552 tremor 9.7
553 posttransplant acute limbic encephalitis 9.7
554 rare hereditary hemochromatosis 9.7
555 toxic oil syndrome 9.7
556 pneumococcal meningitis 9.7
557 premature aging 9.7
558 neurofibromatosis, type ii 9.6
559 alcohol dependence 9.6
560 alzheimer disease 9.6
561 alopecia, androgenetic, 1 9.6
562 gastroesophageal reflux 9.6
563 progressive familial heart block, type ia 9.6
564 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.6
565 cerebral cavernous malformations 9.6
566 cleft palate, isolated 9.6
567 major affective disorder 1 9.6
568 episodic kinesigenic dyskinesia 1 9.6
569 erythermalgia, primary 9.6
570 endosteal hyperostosis, autosomal dominant 9.6
571 hyperostosis frontalis interna 9.6
572 intussusception 9.6
573 klippel-trenaunay-weber syndrome 9.6
574 meniere disease 9.6
575 myositis 9.6
576 neutrophil migration 9.6
577 ocular cicatricial pemphigoid 9.6
578 teratoma, ovarian 9.6
579 pancreatitis, hereditary 9.6
580 pemphigus vulgaris, familial 9.6
581 porphyria cutanea tarda, type i 9.6
582 porphyria cutanea tarda 9.6
583 hutchinson-gilford progeria syndrome 9.6
584 pulmonary hypertension, primary, 1 9.6
585 retinal detachment 9.6
586 schistosoma mansoni infection, susceptibility/ 9.6
587 tetralogy of fallot 9.6
588 renal hypodysplasia/aplasia 1 9.6
589 volvulus of midgut 9.6
590 williams-beuren syndrome 9.6
591 alpha-ketoglutarate dehydrogenase deficiency 9.6
592 anencephaly 9.6
593 autism 9.6
594 central hypoventilation syndrome, congenital 9.6
595 lung cancer 9.6
596 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.6
597 corpus callosum, agenesis of 9.6
598 pituitary adenoma 4, acth-secreting 9.6
599 gaucher disease, type i 9.6
600 hemihyperplasia, isolated 9.6
601 histidinemia 9.6
602 hypoascorbemia 9.6
603 hypogonadism, male 9.6
604 immune deficiency disease 9.6
605 chylomicron retention disease 9.6
606 maple syrup urine disease 9.6
607 mycosis fungoides 9.6
608 3-methylglutaconic aciduria, type iii 9.6
609 pancreatic agenesis 1 9.6
610 periodontitis, chronic 9.6
611 laron syndrome 9.6
612 pituitary hormone deficiency, combined, 2 9.6
613 asplenia, isolated congenital 9.6
614 tardive dyskinesia 9.6
615 thymoma, familial 9.6
616 kearns-sayre syndrome 9.6
617 mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes 9.6
618 sacral defect with anterior meningocele 9.6
619 wilms tumor 5 9.6
620 xanthomatosis 9.6
621 cerebral cavernous malformations 2 9.6
622 acromelic frontonasal dysostosis 9.6
623 sickle cell anemia 9.6
624 huntington disease-like 3 9.6
625 glycine encephalopathy 9.6
626 propionic acidemia 9.6
627 huntington disease-like 2 9.6
628 creatinine clearance quantitative trait locus 9.6
629 resting heart rate, variation in 9.6
630 psoriatic arthritis 9.6
631 mycobacterium tuberculosis 1 9.6
632 endometrial cancer 9.6
633 aspirin resistance 9.6
634 major depressive disorder 9.6
635 carney complex variant 9.6
636 aplastic anemia 9.6
637 preterm premature rupture of the membranes 9.6
638 malaria 9.6
639 myopia 16, autosomal dominant 9.6
640 lung cancer susceptibility 3 9.6
641 ectodermal dysplasia-syndactyly syndrome 2 9.6
642 cyanosis, transient neonatal 9.6
643 nestor-guillermo progeria syndrome 9.6
644 dengue virus 9.6
645 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.6
646 alacrima, achalasia, and mental retardation syndrome 9.6
647 leukemia, acute lymphoblastic 3 9.6
648 helix syndrome 9.6
649 congenital disorder of glycosylation with defective fucosylation 1 9.6
650 aspiration pneumonia 9.6
651 visceral heterotaxy 9.6
652 chorioamnionitis 9.6
653 androgenic alopecia 9.6
654 hemidystonia 9.6
655 villous adenoma 9.6
656 autism spectrum disorder 9.6
657 apraxia 9.6
658 basal ganglia calcification 9.6
659 myelomeningocele 9.6
660 lymphoproliferative syndrome 9.6
661 ectopic cushing syndrome 9.6
662 polycystic kidney disease 9.6
663 neuroretinitis 9.6
664 osteomyelitis 9.6
665 dermatomyositis 9.6
666 parotitis 9.6
667 sialadenitis 9.6
668 dressler's syndrome 9.6
669 microphthalmia 9.6
670 methemoglobinemia 9.6
671 malignant hypertension 9.6
672 hand, foot and mouth disease 9.6
673 microcephaly 9.6
674 amnestic disorder 9.6
675 dissociative disorder 9.6
676 lipoid nephrosis 9.6
677 neonatal anemia 9.6
678 keratomalacia 9.6
679 diphtheria 9.6
680 mitral valve insufficiency 9.6
681 dental pulp necrosis 9.6
682 lyme disease 9.6
683 cortical blindness 9.6
684 clubfoot 9.6
685 nephrotic syndrome 9.6
686 esophagitis 9.6
687 inflammatory spondylopathy 9.6
688 pica disease 9.6
689 chagas disease 9.6
690 neurogenic bladder 9.6
691 lymphocytic choriomeningitis 9.6
692 dysentery 9.6
693 pancytopenia 9.6
694 retinal ischemia 9.6
695 hemolytic-uremic syndrome 9.6
696 acute kidney tubular necrosis 9.6
697 chronic progressive external ophthalmoplegia 9.6
698 hypertrophic pyloric stenosis 9.6
699 pyloric stenosis 9.6
700 leiomyoma 9.6
701 quadriplegia 9.6
702 dilated cardiomyopathy 9.6
703 balanitis 9.6
704 typhoid fever 9.6
705 porphyria 9.6
706 beriberi 9.6
707 acute closed-angle glaucoma 9.6
708 squamous cell papilloma 9.6
709 schistosomiasis 9.6
710 epicondylitis 9.6
711 oligospermia 9.6
712 oral candidiasis 9.6
713 suppurative cholangitis 9.6
714 neuroleptic malignant syndrome 9.6
715 cholera 9.6
716 alcohol use disorder 9.6
717 ventricular septal defect 9.6
718 heart septal defect 9.6
719 duodenal ulcer 9.6
720 hepatitis c 9.6
721 optic nerve disease 9.6
722 gaucher's disease 9.6
723 enthesopathy 9.6
724 hepatitis b 9.6
725 thrombocytosis 9.6
726 pharyngitis 9.6
727 colon adenocarcinoma 9.6
728 craniosynostosis 9.6
729 neonatal jaundice 9.6
730 wernicke encephalopathy 9.6
731 opiate dependence 9.6
732 papilloma 9.6
733 kidney cancer 9.6
734 endocrine system disease 9.6
735 bronchiolitis 9.6
736 severe acute respiratory syndrome 9.6
737 cockayne syndrome 9.6
738 cystic kidney disease 9.6
739 anuria 9.6
740 astrocytoma 9.6
741 interstitial lung disease 9.6
742 gingival overgrowth 9.6
743 cystadenocarcinoma 9.6
744 gallbladder cancer 9.6
745 central nervous system lymphoma 9.6
746 rhabdomyosarcoma 9.6
747 thymoma 9.6
748 vaccinia 9.6
749 teratocarcinoma 9.6
750 partial motor epilepsy 9.6
751 temporal lobe epilepsy 9.6
752 carotid artery thrombosis 9.6
753 mammary paget's disease 9.6
754 cellulitis 9.6
755 mixed connective tissue disease 9.6
756 middle cerebral artery infarction 9.6
757 mucinous cystadenocarcinoma 9.6
758 ovarian cystadenocarcinoma 9.6
759 retinitis 9.6
760 plexopathy 9.6
761 skin disease 9.6
762 ovary adenocarcinoma 9.6
763 extramedullary plasmacytoma 9.6
764 plasmacytoma 9.6
765 protein c deficiency 9.6
766 chromophobe adenoma 9.6
767 lung squamous cell carcinoma 9.6
768 mouth disease 9.6
769 intracranial thrombosis 9.6
770 pulmonary immaturity 9.6
771 myofibroma 9.6
772 elephantiasis 9.6
773 alcoholic pancreatitis 9.6
774 mixed glioma 9.6
775 ovarian cyst 9.6
776 arteriolosclerosis 9.6
777 schizoaffective disorder 9.6
778 ovarian germ cell teratoma 9.6
779 anterolateral myocardial infarction 9.6
780 acquired immunodeficiency syndrome 9.6
781 connective tissue disease 9.6
782 spondylitis 9.6
783 parasagittal meningioma 9.6
784 mitochondrial myopathy 9.6
785 acth-secreting pituitary adenoma 9.6
786 axonal neuropathy 9.6
787 monoclonal gammopathy of uncertain significance 9.6
788 neuroblastoma 9.6
789 gastrointestinal system disease 9.6
790 ocular hypotension 9.6
791 periapical periodontitis 9.6
792 polycythemia 9.6
793 intestinal obstruction 9.6
794 influenza 9.6
795 arthritis 9.6
796 mucormycosis 9.6
797 polyhydramnios 9.6
798 bullous pemphigoid 9.6
799 monocytic leukemia 9.6
800 vasculitis 9.6
801 in situ carcinoma 9.6
802 lupus erythematosus 9.6
803 narcolepsy 9.6
804 degenerative disc disease 9.6
805 pemphigus 9.6
806 tyrosinemia 9.6
807 ocular hypertension 9.6
808 cleft lip 9.6
809 intracranial hypertension 9.6
810 pathologic nystagmus 9.6
811 systolic heart failure 9.6
812 alopecia areata 9.6
813 periodontosis 9.6
814 hypereosinophilic syndrome 9.6
815 acid sphingomyelinase deficiency 9.6
816 glucose transporter type 1 deficiency syndrome 9.6
817 mitochondrial disorders 9.6
818 sickle cell disease 9.6
819 47, xxy 9.6
820 aminoacidopathies 9.6
821 bronchopulmonary dysplasia 9.6
822 carcinoid syndrome 9.6
823 dwarfism 9.6
824 familial glucocorticoid deficiency 9.6
825 fetal hydantoin syndrome 9.6
826 glucagonoma 9.6
827 granulocytopenia 9.6
828 hypoadrenalism 9.6
829 hypoaldosteronism 9.6
830 idiopathic spinal cord herniation 9.6
831 lymphosarcoma 9.6
832 mast cell activation syndrome 9.6
833 microscopic polyangiitis 9.6
834 mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes 9.6
835 neisseria meningitidis infection 9.6
836 neonatal meningitis 9.6
837 non-involuting congenital hemangioma 9.6
838 ovarian epithelial cancer 9.6
839 pemphigus foliaceus 9.6
840 post-transplant lymphoproliferative disease 9.6
841 postorgasmic illness syndrome 9.6
842 primary central nervous system lymphoma 9.6
843 tuberculous meningitis 9.6
844 wallerian degeneration 9.6
845 clopidogrel resistance 9.6
846 cerebral aneurysms 9.6
847 cerebral atrophy 9.6
848 cerebral beriberi 9.6
849 chronic pain 9.6
850 dysautonomia 9.6
851 extrapontine myelinolysis 9.6
852 headache 9.6
853 hypotonia 9.6
854 myoclonus 9.6
855 paraneoplastic syndromes 9.6
856 syncope 9.6
857 cerebrofacial arteriovenous metameric syndrome 9.6
858 inflammatory myopathy with abundant macrophages 9.6
859 periodic paralysis 9.6
860 specific language disorder 9.6
861 ciliopathy 9.6
862 paracetamol poisoning 9.6
863 scorpion envenomation 9.6
864 deep dermatophytosis 9.6
865 methanol poisoning 9.6
866 recurrent acute pancreatitis 9.6
867 pik3ca-related overgrowth syndrome 9.6
868 acute adrenal insufficiency 9.6
869 glomerular disease 9.6
870 skeletal muscle disease 9.6
871 rare movement disorder 9.6

Graphical network of the top 20 diseases related to Hyperglycemia:



Diseases related to Hyperglycemia

Symptoms & Phenotypes for Hyperglycemia

UMLS symptoms related to Hyperglycemia:


seizures, fever, dyspnea, edema, cachexia, vertigo, headache, syncope, cyanosis, icterus, signs and symptoms, signs and symptoms, digestive, hot flushes, symptoms

MGI Mouse Phenotypes related to Hyperglycemia:

45 (showing 14, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.39 ABCC8 ADIPOQ AKR1B1 ALB DPP4 GCK
2 growth/size/body region MP:0005378 10.36 ADIPOQ AKR1B1 DPP4 GCK HNF1A IAPP
3 endocrine/exocrine gland MP:0005379 10.32 ABCC8 ADIPOQ ALB DPP4 GCK HNF1A
4 cellular MP:0005384 10.25 ADIPOQ ALB GCK HNF1A IGF1 INS
5 adipose tissue MP:0005375 10.24 ADIPOQ HNF1A IGF1 INS INSR IRS1
6 cardiovascular system MP:0005385 10.22 ADIPOQ ALB GCK IGF1 INS INSR
7 immune system MP:0005387 10.18 ADIPOQ ALB IAPP IGF1 INS INSR
8 mortality/aging MP:0010768 10.17 ADIPOQ AKR1B1 ALB GCK HNF1A IGF1
9 digestive/alimentary MP:0005381 10.1 ALB HNF1A INS INSR LEP PDX1
10 liver/biliary system MP:0005370 10.07 ADIPOQ ALB GCK HNF1A INS INSR
11 muscle MP:0005369 10 ADIPOQ ALB HNF1A IGF1 INS INSR
12 renal/urinary system MP:0005367 9.73 ADIPOQ AKR1B1 ALB GCK HNF1A IGF1
13 no phenotypic analysis MP:0003012 9.7 ABCC8 HNF1A INS KCNJ11 PDX1 PPARG
14 skeleton MP:0005390 9.4 ADIPOQ AKR1B1 HNF1A IAPP IGF1 INS

Drugs & Therapeutics for Hyperglycemia

Drugs for Hyperglycemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 724, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pancrelipase Approved, Investigational Phase 4 53608-75-6
2
Lixisenatide Approved Phase 4 320367-13-3
3
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
4
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
5
Parecoxib Approved Phase 4 198470-84-7
6
Darunavir Approved Phase 4 635728-49-3, 206361-99-1 213039
7
Rilpivirine Approved Phase 4 500287-72-9
8
Cobicistat Approved Phase 4 1004316-88-4
9
Insulin glulisine Approved Phase 4 207748-29-6
10
Gliclazide Approved Phase 4 21187-98-4 3475
11
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
12
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
13
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492 6473866
14
Glipizide Approved, Investigational Phase 4 29094-61-9 3478
15
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
16
Linagliptin Approved Phase 4 668270-12-0 10096344
17
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
18
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
19
Ziprasidone Approved Phase 4 146939-27-7 60854
20
Glimepiride Approved Phase 4 93479-97-1 3476
21
Remifentanil Approved Phase 4 132875-61-7 60815
22
Simvastatin Approved Phase 4 79902-63-9 54454
23
Pramlintide Approved, Investigational Phase 4 151126-32-8
24
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
25
Nateglinide Approved, Investigational Phase 4 105816-04-4 60026
26
Risperidone Approved, Investigational Phase 4 106266-06-2 5073
27
Mifepristone Approved, Investigational Phase 4 84371-65-3 55245
28
Febuxostat Approved Phase 4 144060-53-7 134018
29
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
30
Metoprolol Approved, Investigational Phase 4 51384-51-1, 37350-58-6 4171
31
Moxifloxacin Approved, Investigational Phase 4 151096-09-2, 354812-41-2 152946
32
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
33
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
34
Glycerol Approved, Investigational Phase 4 56-81-5 753
35
Atenolol Approved Phase 4 29122-68-7 2249
36
Enalaprilat Approved Phase 4 76420-72-9 6917719
37
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
38
Clozapine Approved Phase 4 5786-21-0 2818
39
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
40
Cetirizine Approved Phase 4 83881-51-0 2678
41
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
42
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
43
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
44
Mycophenolic acid Approved Phase 4 24280-93-1 446541
45
Stavudine Approved, Investigational Phase 4 3056-17-5 18283
46
Testosterone Approved, Experimental, Investigational Phase 4 58-22-0, 481-30-1 6013 10204